Company intelligence / Profile preview

LenioBio

Düsseldorf, North Rhine-Westphalia, Germanyleniobio.com ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

LenioBio’s ALiCE® platform enables rapid (<48 hours), scalable production of complex proteins—including those previously considered inexpressible—without the need for living cells. The technology has demonstrated success in producing diverse protein classes and has received CEPI funding to validate its use in accelerating vaccine candidate production against epidemic threats within 20–40 days. The company does not develop its own clinical-stage therapeutics but empowers partners across preclinical to commercial stages with its technology

Therapeutic areas: Infectious Diseases
Modalities: Protein-based therapeutics (including antigens, antibodies, vaccines, membrane proteins such as GPCRs)
Industry: Non-Drug Biotech

Partnerships

Labscoop (strategic partnership to expand access across North America)CEPI (Coalition for Epidemic Preparedness Innovations) funding partnership for pandemic response applicationsTechnology origins from DowDuPont and Fraunhofer Institute collaborations

Beyond the preview

Go deeper on LenioBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LenioBio.

Explore the full profile